Investment analysts at HC Wainwright increased their Q3 2025 earnings estimates for shares of Collegium Pharmaceutical in a note issued to investors on Monday, March 24th. HC Wainwright analyst O.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback